Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -25.83% is 34% below its 5-year average of -19.29%, near the low end of its 5-year range (-34.84%–17.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.91% above its 12-month average of -28.05%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -25.83%.
RETURN ON EQUITY (ROE)
-25.83%
RETURN ON EQUITY (ROE) AVG TTM
-28.05%
RETURN ON EQUITY (ROE) AVG 3Y
-20.62%
RETURN ON EQUITY (ROE) AVG 5Y
-19.29%
RETURN ON EQUITY (ROE) AVG 10Y
-18.95%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.91%
CURRENT VS 3Y AVG
-25.29%
CURRENT VS 5Y AVG
-33.93%
CURRENT VS 10Y AVG
-36.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 92 covered companies
CURRENT VS SECTOR MEDIAN
-325.79%
vs the sector median at left
CRISPR Therapeutics AG
Market Cap
$5.35B
Return on Equity (ROE)
-25.83%
TTM Avg
-28.05%
3Y Avg
-20.62%
5Y Avg
-19.29%
Market Cap
$5.22B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$5.10B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.61B
Return on Equity (ROE)
-161.00%
TTM Avg
-110.38%
3Y Avg
-86.51%
5Y Avg
-75.97%
Market Cap
$6.47B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$6.63B
Return on Equity (ROE)
33.11%
TTM Avg
27.03%
3Y Avg
27.48%
5Y Avg
31.41%
Market Cap
$2.76B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$8.02B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$2.52B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | -25.83% | -28.05% | -20.62% | -19.29% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 18.24% | 20.62% | 17.32% | 27.02% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 8.67% | 8.42% | 7.80% | 5.80% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -161.00% | -110.38% | -86.51% | -75.97% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -43.83% | 25.09% | 5.57% | 0.40% |
| Chemed Corporation (CHE)vs › | $6.63B | 33.11% | 27.03% | 27.48% | 31.41% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 29.28% | 27.86% | 4.54% | -12.45% |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 26.84% | -21.41% | -36.14% | -25.75% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -8.00% | -28.91% | -27.68% | -39.13% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -56.71% | -50.91% | -55.48% | -35.68% |
ROE
-25.8%
ROA
-17.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -25.83% |
| 2026-03-31 | -31.33% |
| 2025-12-31 | -30.26% |
| 2025-09-30 | -25.49% |
| 2025-06-30 | -27.34% |
| 2025-03-31 | -21.08% |
| 2024-12-31 | -18.96% |
| 2024-09-30 | -12.35% |
| 2024-06-30 | -13.42% |
| 2024-03-31 | -10.42% |
| 2023-12-31 | -8.16% |
| 2023-09-30 | -20.46% |
| 2023-06-30 | -22.90% |
| 2023-03-31 | -28.25% |
| 2022-12-31 | -34.67% |
| 2022-09-30 | -34.84% |
| 2022-06-30 | -30.30% |
| 2022-03-31 | 13.88% |
| 2021-12-31 | 15.74% |
| 2021-09-30 | 16.39% |
| 2021-06-30 | 17.15% |
| 2021-03-31 | -21.73% |
| 2020-12-31 | -20.96% |
| 2020-09-30 | -15.73% |
| 2020-06-30 | 2.15% |
| 2020-03-31 | 5.14% |
| 2019-12-31 | 7.12% |
| 2019-09-30 | -1.90% |
| 2019-06-30 | -54.51% |
| 2019-03-31 | -48.73% |
| 2018-12-31 | -42.07% |
| 2018-09-30 | -28.10% |
| 2018-06-30 | -34.41% |
| 2018-03-31 | -25.89% |
| 2017-12-31 | -36.39% |
| 2017-09-30 | -28.72% |
| 2017-06-30 | -20.92% |
| 2017-03-31 | -16.84% |
| 2016-12-31 | -9.96% |
| 2016-06-30 | -32.69% |
| 2016-03-31 | -34.16% |
